- MRSA is a major nosocomial pathogen
- Causes severe morbidity and mortality worldwide
- Endemic in many European and American hospitals
- 40% of nosocomial Staph. aureus infections are methicillin resistant
- Many in-patients are colonised ot infected
- 25% hospital personnel may be carriers
- Found on inguinal, perinea, or axillary skin and anterior nares
- Spread by hand, usually of health care workers
Microbiology
- Staph aureus is a gram-positive coccus
- Forms clusters on culture medium
- Methicillin resistance is mediated by the mecA gene
- Encodes a single additional penicillin binding protein PBP2a
- Expression of mecA can be either constitutive or inducible
Risk factors for MRSA colonisation
- Advanced age
- Male gender
- Previous hospitalisation
- Length of hospitalisation
- Stay in ICU
- Chronic medical illness
- Prior and prolonged antibiotic therapy
- Presence and size of a wound
- Exposure to colonised or infected patient
- Presence of invasive indwelling device
Clinical presentations
- Pneumonia
- Surgical site infections
- Line sepsis
- Intra-abdominal infections
- Osteomyelitis
- Toxic shock syndrome
Infection control
- Screening of patients and staff
- Hand washing
- Use of gowns and gloves
- Topical antimicrobials
- Isolation of patients
- Environmental cleaning
Management
- Vancomycin is the antibiotic of choice
- Teicoplanin may be used if the isolate is resistant to vancomycin
- Linezolid is new class of antimicrobial agent
- Active against MRSA and VRE
- Quinupristin / dalfopristin are newer alternative
Bibliography
Haddadin A S, Fappiano S A, Lipsett P A. Methicillin resistant Staphylococcus aureus (MRSA)
in the intensive care unit. Postgrad Med J 2002; 78: 385-392.
Hardy K J, Hawkey P M, Gao F et al. Methicillin resistant Staphylococcus aureus in
the critically ill. Br J Anaesth 2004; 92: 121-130.
Loeb M, Main C, Walker-Dilks C et al. Antimicrobial drugs for treating
methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst
Rev 2003: CD003340.
Simor A E. Containing methicillin resistant Staph aureus: Surveillance, control and
treatment methods. Postgrad Med 2001; 110: 43-48.
Wilson P. Linezolid: a new antibiotic for gram-positive infections. Hosp Med
2001: 62: 682-686. |